Tune In

   


Basics of Prostate Cancer

April 17, 2018
Length
18 mins
Overview
This webinar will focus on describing what the prostate is and what it does.  Risk factors for the development of prostate cancer will be described as well as what symptoms and signs might be present that would give a clue to abnormalities of prostate health, including cancer.  If cancer is suspected, a brief description of what diagnostic tests might be needed will be reviewed as well as next steps after a diagnosis of prostate cancer is established.
Speaker
Dr. Scott North is a graduate of the University of Ottawa medical school and he received his training in Internal Medicine and Medical Oncology at the University of Alberta.  He is also keenly interested in medical education and pursued a Masters in Health Professions Education from the University of Illinois at Chicago.  He is the Section Chief of Medical Oncology at the Cross Cancer Institute in Edmonton, AB and the Division Director of Medical Oncology within the Department of Oncology at the University of Alberta.  He currently serves on the executive of the Genitourinary site for the Canadian Cancer Trials Group and the Canadian Uro-Oncology Group.  His clinical practice is exclusively in the area of genitourinary cancer.
Prostate Cancer 101


Health and Wellness


June 12, 2018
Length
15 mins
Overview
Research indicates that low muscle mass is a powerful and independent predictor of poorer health outcomes in the general public, particularly for those affected by cancer. In this webinar, Dr. Carla Prado discusses what leads to muscle loss, how you can prevent muscle loss with proper nutrition and what unique variables need to be considered for prostate cancer patients. Dr. Prado breaks down some of the essential nutrients for the maintenance of strong bones and muscle mass by providing simple guidelines on healthy eating.
Speaker
Dr. Carla Prado is a Registered Dietitian and an Assistant Professor at the University of Alberta, and a Campus Alberta Innovates Program (CAIP) Chair in Nutrition, Food and Health. She is also the Director of the Human Nutrition Research Unit. Dr. Prado is an expert in assessing nutritional status through the precise measurement of body composition and energy metabolism. The focus of her current research program is to develop targeted nutrition interventions for the prevention and treatment of sarcopenia in cancer.
Dr. Prado
May 15, 2018
Length
18 mins
Overview
In this webinar, Dr. Carla Prado discusses the findings of a recently conducted review on diet and lifestyle factors that were found to influence the risk of prostate cancer. A list of the strongest risk and protective factors against prostate cancer are reviewed along with strategies for maintaining a healthy lifestyle. Furthermore, current guidelines for healthy living, including Canada’s Food Guide, are broken down so they can be implemented into your daily life.
Speaker
Dr. Carla Prado is a Registered Dietitian and an Assistant Professor at the University of Alberta, and a Campus Alberta Innovates Program (CAIP) Chair in Nutrition, Food and Health. She is also the Director of the Human Nutrition Research Unit. Dr. Prado is an expert in assessing nutritional status through the precise measurement of body composition and energy metabolism. The focus of her current research program is to develop targeted nutrition interventions for the prevention and treatment of sarcopenia in cancer.
May 01, 2018
Length
19 mins
Overview
The ability to apply economic thinking when making a choice or a decision can be important partly because of limited resources which we are faced with in health care. This webinar will introduce participants to economic evaluation and its potential to help us understand the value of health intervention. Economic evaluation is a technique which enables users to compare two or more health interventions or to quantify a potential impact of a health initiative through an economic lens. Economic evaluation could provide another piece of evidence to assist various groups such as health providers, decision-makers, and policy-makers in their decision-making process.
Speaker
Dr. Wanrudee Isaranuwatchai is a Research Scientist and the Director of the Centre for Excellence in Economic Analysis Research at St. Michael’s Hospital. She is also an Assistant Professor at the Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health at the University of Toronto, and a Health Economist at the Canadian Centre for Applied Research in Cancer Control. Her research focuses on how to apply economic evaluation in the real world setting as well as how to advance methods in economic evaluation. She has experience conducting economic evaluations using person-level data and decision modeling. She has collaborated with researchers and decision-makers in various areas to help communicate the value of health initiatives using economic evidence. Dr. Isaranuwatchai is dedicated to promoting the use of evidence in healthcare decision making.
Dr. Wanrudee Isaranuwatchai
November 14, 2017
Length
11 mins
Overview
This presentation will describe the TrueNTH Lifestyle Management resources that have been developed and disseminated for prostate cancer survivors as well as the health and fitness professionals working with them. An overview of the community-based programming as well as the online resources will be discussed.
Speaker
Dr. Culos-Reed is a Professor of Health and Exercise Psychology in the Faculty of Kinesiology at the University of Calgary. Her research takes a multidisciplinary approach to understanding and improving the quality of life of cancer survivors by developing physical activity programs to address challenges they face throughout treatment and survivorship.

The TrueNTH Lifestyle Management program was awarded by Prostate Cancer Canada and is proudly funded by the Movember Foundation.
TrueNTH Lifestyle Management: Wellness Resources for Men with Prostate Cancer

Treatment and Side Effects


May 29, 2018
Length
24 mins
Overview
This webinar reviews the sexual side effects that may occur after prostate cancer treatment. The risk factors of post-prostatectomy erectile dysfunction, recovery time and the benefits and limitations of available treatments will be described including the use of PDE5 inhibitors, vacuums, injections and other devices. 
Speaker
Dr. Dean Elterman is a Urologist and Medical Director at the Prostate Cancer Rehabilitation Clinic at Princess Margaret Cancer Centre. He has worked in the areas of men’s health and survivorship at the Iris Cantor Men’s Health Center at New York Presbyterian Hospital/Weill Cornell Medical College and at the University of Toronto. Some of his current research interests include male health, voiding dysfunction and reconstruction including BPH, incontinence and sexual dysfunction (penile prosthetic surgery). 
Dean Elterman
March 29, 2018
Length
23 mins
Overview
This presentation takes a closer look at a critical time within the prostate cancer disease journey between the localized and advanced disease state. Metastasis, when the cancer spreads to a different part of the body, is currently targeted by multiple treatment options available in the market. With the recent SPARTAN and PROSPER clinical trials, there are new drug developments that may target the non-metastatic castration resistant prostate cancer window to further delay metastases. Key tools and imaging options in detecting metastases are also discussed.
Speaker
Dr. Robert Hamilton is an uro-oncologic surgeon specializing in prostate cancer at the Princess Margaret Cancer Centre. He has expertise in minimally invasive surgeries, including robotic surgery. Dr. Hamilton sees patients at all different stages of prostate cancer from those at risk to this with early diagnoses to advanced disease. His research interests in prostate cancer include the study of statins and metformin in prostate cancer prevention; whether genetic markers can be used to predict who will benefit from chemoprevention; and biomarkers of prostate cancer aggressiveness.
Dr. Robert Hamilton
March 13, 2018
Length
13 mins
Overview
This short webinar will address key aspects of the impact of prostate cancer treatment on the couple. It is widely acknowledged that treatment for prostate cancer results in sexual side effects that impact both the man and his partner. These side effects often impact on the couple's relationship in a negative way and cause distress for both individuals. This webinar will address what these issues are as well as making suggestions to mitigate the effects on the couple.
Speaker
Dr. Anne Katz is a certified sexuality counselor at CancerCare Manitoba and Clinical Nurse Specialist at the Manitoba Prostate Centre. Dr. Katz is the editor of the Oncology Nursing Forum, the premier research journal of the Oncology Nursing Society. She was inducted into the American Academy of Nursing in 2014. She has educated health care providers and cancer survivors about cancer, sexuality, and survivorship around the world and is an avid blogger for ASCO Connections.
Dr. Anne Katz
February 27, 2018
Length
14 mins
Overview
Prostate cancer which has spread outside of the prostate gland is treated with systemic therapy. However, these treatments are not curative. Understanding the biological reasons for why these treatments do not work or become ineffective is important to identify better ways to treat patients. This presentation will give an overview of current understanding of why prostate cancers develop resistance to current therapies.
Speaker
Dr. Paul Toren completed his medical school at Queen's University in Kingston, Ontario and his urology residency and a clinical uro-oncology fellowship at the University of Toronto. Subsequently, he completed a two-year research fellowship at the Vancouver Prostate Centre under the mentorship of Dr. Martin Gleave. Concurrently, he enrolled in and recently completed a doctorate in experimental medicine in the laboratory of Dr. Amina Zoubeidi.  Since 2015, he works as a clinician-scientist in the Department of Surgery at Laval University, where his laboratory focuses on translational prostate cancer research.
Dr. Paul Toren
February 13, 2018
Length
28 mins
Overview
This presentation is an overview of the most common and serious side effects that are possible for men who are treated for prostate cancer.  It compares and contrasts the 4 main treatment options: surgery, low dose rate (LDR; permanent seed) brachytherapy, high dose rate (HDR: temporary seed) brachytherapy, and external beam radiotherapy (EBRT).   This is a presentation that men and their families who are still undecided as to what treatment option they prefer may find useful as it compares the risk of developing a side effect of therapy (e.g. bladder leaking, rectal bleeding, etc) between the four options.  This presentation is based on the best available data in the medical literature that a collaborative group of surgeons and oncologists agreed upon to help make sure patients are provided consistent, high quality information.
Speaker
Dr. Danny Vesprini is a Radiation Oncologist specializing in Prostate Cancer at the Sunnybrook Odette Cancer Centre, Affiliate Scientist at the Sunnybrook Research Institute and an Assistant Professor at the University of Toronto. He is one of the Principle Investigators of the Sunnybrook Active Surveillance Program, the Director of the Male Oncology Research and Education (MORE) program which focuses on men that have developed or are at a high risk of developing aggressive prostate cancer.
Dr. Danny Vesprini
January 30, 2018
Length
17 mins
Overview
The objective of this presentation is to educate patients, their partners and their loved ones to learn about radical prostatectomy as a treatment option for prostate cancer. We will discuss what the surgery entails and what to expect during the early recovery period. This will include consideration of possible complications of surgery and the need for sexual and bladder rehabilitation after surgery. Finally we will also discuss additional cancer therapies that may be offered after radical prostatectomy and how patients are followed to ensure they remain cancer free. 
Speaker
Dr. Peter Black is a Urologic Oncologist at Vancouver General Hospital, a Research Scientist at the Vancouver Prostate Centre, and Professor in the Department of Urologic Sciences at the University of British Columbia. He completed his urologic training at the University of Washington in Seattle and fellowship in urologic oncology at M.D. Anderson Cancer Center in Houston, Texas. He has a clinical subspecialty interest in prostate and bladder cancer and also a translational research program related to both cancers. 
Dr Peter Black
January 16, 2018
Length
23 mins
Overview
This presentation is focused on explaining how radiation therapy works and describes the two main methods of delivering prostate radiotherapy - brachytherapy and external beam radiotherapy. It reviews the main treatment options for low, intermediate and high risk prostate cancer, focusing on the radiotherapy options. This is a video that men and their families may find useful in explaining the different types of radiation and some of the reasons why one modality may be preferred compared to the other options.
Speaker
Dr Danny Vesprini is a Radiation Oncologist specializing in Prostate Cancer at the Sunnybrook Odette Cancer Centre, Affiliate Scientist at the Sunnybrook Research Institute and an Assistant Professor at the University of Toronto. He is one of the Principle Investigators of the Sunnybrook Active Surveillance Program, the Director of the Male Oncology Research and Education (MORE) program which focuses on men that have developed or are at a high risk of developing aggressive prostate cancer.
January 03, 2018
Length
15 mins
Overview

Bill Landry will complete the 3-part series by discussing various exercises and strategies men can use to regain continence following a radical prostatectomy. Viewers will also learn about how real time ultrasound can be used to reach men how to properly complete pelvic floor contractions and functional exercises.

December 12, 2017
Length
14 mins
Overview
This webinar will continue to explore urinary incontinence after radical prostatectomy (RP). Bill Landry will outline the anatomy and physiology of the male urinary system before and after RP surgery, the types of incontinence after RP and pelvic floor muscles.
November 28, 2017
Length
16 mins
Overview
Some men will experience urinary incontinence after radical prostatectomy (RP). Part 1 of this 3-part webinar series will outline how common incontinence is post-surgery, common issues and misconceptions men have following surgery, and the use of a 24-hour pad test at home as a tool to measure progress.
Speaker
Bill Landry graduated from University of Toronto's Physiotherapy program in 1999 and is a member of the Canadian Physiotherapy Association. Bill has a special interest in treating men for urinary incontinence after prostate cancer. He has completed courses and attended international conferences specializing in pelvic floor rehabilitation for PPI.
Bill Landry
Once you register, you should gain access to the webinar right away through your internet browser. If you encounter any issue, please email: expertangle@prostatecancer.ca.
 

Stay tuned for information on upcoming webinars. Click here to view our archived webinar content.

  

For more information and support:


Plaid for Dad


Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.
More

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.
More

Landmark study links tumour evolution to prostate cancer severity

Toronto (April 19, 2018) – Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell, show that the aggressiveness of an individual prostate cancer can be accurately assessed by looking at how that tumour has evolved.
More


Click here for news archive